Injective Protocol (INJ) is currently navigating a crucial phase, trading at approximately $4.32, near its 52-week lows. However, recent technical indicators suggest that a recovery rally may be on the horizon. Our analysis indicates that INJ could aim for a price range of $5.80-$6.50 over the next 4-6 weeks, reflecting a potential upside of 25-50% from its current valuation.
The short-term target for INJ is set between $4.84 and $5.20, marking an anticipated increase of 12-20%. In the medium term, projections have recently been upgraded to the $5.80-$6.50 bracket, indicating a 34-50% rise. A key resistance level to monitor is $5.44, which must be breached for bullish momentum to continue. Conversely, the critical support level lies at $4.16, which represents the area of the 52-week low.
Recent forecasts from analysts illustrate a growing consensus on the bullish prospects for INJ. A prediction made on December 31st targets a range of $6.50-$7.20, bolstered by positive MACD indicators and solid support around $4.35. This marks a significant upgrade from earlier estimates, which initially focused on the $5.20-$5.80 range. The evolution of these predictions highlights the improving technical landscape surrounding INJ.
Technical analysis reveals that INJ is at a pivotal point, with the current price just above the critical support level of $4.16. The MACD histogram has flipped positive, indicating emerging bullish momentum despite an overall negative MACD reading. Additionally, INJ”s position within the Bollinger Bands suggests it is near the lower band, a historically favorable zone for oversold bounces. The RSI currently stands at 36.90, indicating room for upward movement before reaching overbought territory. With a trading volume of $5.2 million on Binance, liquidity remains sufficient for any potential breakout.
For those considering investment strategies, the current levels around $4.32 present an attractive risk-reward scenario for believers in the bullish outlook for INJ. Aggressive traders may consider entering positions near current levels while setting a stop-loss at $4.10 for protection. More cautious investors might wait for a breakout above $4.84, the short-term target, before committing to positions.
In summary, our comprehensive analysis supports a bullish price prediction for INJ, suggesting targets of $5.80-$6.50 in the coming weeks. This forecast is underpinned by oversold conditions, emerging bullish indicators, and a consensus among analysts. Key levels to watch include the $4.35 support for validation of bullish momentum and the $5.44 resistance as a gateway to higher price targets. The timeline for this prediction centers on late January to early February 2026, with confirmation expected if INJ can reclaim the $4.84-$5.20 range within the next 7-10 days. Should INJ fail to maintain above the $4.16 support, a reassessment of the bullish outlook will be necessary.
